Oligogenic genetic variation of neurodegenerative disease genes in 980 postmortem human brains
Keogh MJ., Wei W., Aryaman J., Wilson I., Talbot K., Turner MR., McKenzie C-A., Troakes C., Attems J., Smith C., Al Sarraj S., Morris CM., Ansorge O., Pickering-Brown S., Jones N., Ironside JW., Chinnery PF.
<jats:sec><jats:title>Background</jats:title><jats:p>Several studies suggest that multiple rare genetic variants in genes causing monogenic forms of neurodegenerative disorders interact synergistically to increase disease risk or reduce the age of onset, but these studies have not been validated in large sporadic case series.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We analysed 980 neuropathologically characterised human brains with Alzheimer’s disease (AD), Parkinson’s disease-dementia with Lewy bodies (PD-DLB), frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) and age-matched controls. Genetic variants were assessed using the American College of Medical Genetics criteria for pathogenicity. Individuals with two or more variants within a relevant disease gene panel were defined as ‘oligogenic’.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The majority of oligogenic variant combinations consisted of a highly penetrant allele or known risk factor in combination with another rare but likely benign allele. The presence of oligogenic variants did not influence the age of onset or disease severity. After controlling for the single known major risk allele, the frequency of oligogenic variants was no different between cases and controls.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>A priori, individuals with AD, PD-DLB and FTD-ALS are more likely to harbour a known genetic risk factor, and it is the burden of these variants in combination with rare benign alleles that is likely to be responsible for some oligogenic associations. Controlling for this bias is essential in studies investigating a potential role for oligogenic variation in neurodegenerative diseases.</jats:p></jats:sec>